Human TNF-alpha (Research Grade Golimumab Biosimilar) Antibody, Novus Biologicals™

Human Monoclonal Antibody

Product Code	Brand	Quantity
30116267	R&D Systems MAB11494-100	100 μg
30116935	R&D Systems MAB11494-SP	25 μg

Description

TNF-alpha Monoclonal antibody specifically detects TNF-alpha in Human samples. It is validated for ELISA

Specifications

• Antigen: TNF-alpha
• Applications: ELISA
• Conjugate: Unconjugated
• Host Species: Human
• Target Species: Human
• Gene Accession No.: P01375
• Gene ID (Entrez): 7124
• Isotype: IgG1
• Purification Method: Protein A or G purified from ascites
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.

• Clone: Hu213
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. See Certificate of Analysis for details. *Small pack size (-SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
• Gene Alias: APC1 protein, Cachectin, Cachetin, DIF, TNF, TNF, monocyte-derived, TNF-a, TNFA, TNFalpha, TNF-alphacachectin, TNFATNF, macrophage-derived, TNFG1F, TNFSF1A, TNFSF2, TNFSF2TNF superfamily, member 2, tumor necrosis factor, tumor necrosis factor (TNF superfamily, member 2), tumor necrosis factor alpha, Tumor necrosis factor ligand superfamily member 2, tumor necrosis factor-alpha
• Immunogen: E. coli-derived recombinant human TNF-alpha , Gly57-Leu233 (predicted), Accession # P01375
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.